Literature DB >> 28202420

Out-of-hospital cardiac arrest (OHCA) attended by mobile emergency teams with a physician on board. Results of the Spanish OHCA Registry (OSHCAR).

Fernando Rosell-Ortiz1, Xavier Escalada-Roig2, Patricia Fernández Del Valle3, Luis Sánchez-Santos4, José M Navalpotro-Pascual5, Alfredo Echarri-Sucunza6, José M Adsuar-Quesada7, Isabel Ceniceros-Rozalén8, José I Ruiz-Azpiazu9, Karlos Ibarguren-Olalde10, Nuria López-Cabeza11, María V Mier-Ruiz12, Enrique Martín-Sánchez13, Marta Martínez Del Valle14, Guadalupe Inza-Muñoz15, Juan A Cordero Torres16, María J García-Ochoa17, José A Cortés-Ramas18, Raúl Canabal-Berlanga19, Rafael Zoyo López-Navarro20, Juan B López-Messa21, Javier García Del Águila22, Daniel Alonso-Moreno10, Carmen Pozo-Pérez11, José Bravo-Castello16, Natividad Ramos-García19, Ignacio Gómez-Larrosa20, Francisco J Mellado-Vergel23.   

Abstract

Most survival outcomes in out-of-hospital cardiac arrest (OHCA) are provided by emergency medical services (EMS) without a doctor on board. Our objective was to determine such outcomes in a whole country with public physician-led EMS.
METHODS: We analyzed data from a nationwide prospective registry of OHCA cases attended by 19 public EMS in Spain, covering the period from 1-October 2013 to 30-October 2014.
RESULTS: Advanced life support (ALS) was initiated in 9347 cases (incidence 18.6 cases/105 inhabitants per year). Resuscitation was considered futile in 558 cases (5.9%), and ALS was continued in 8789 cases (94.1%); mean age 63.5±17 years, 72.1% men. Initial rhythm was shockable in 22.1% of cases. Basic life support (BLS) was provided by bystanders in 1602 (24%) cases (635 of them with telephone assistance from the dispatch center). Of 8789 patients receiving ALS, 72.1% men, 2669 (30.4%) patients had return of spontaneous circulation on hospital arrival, 50.6% when the initial rhythm was shockable. Hospital discharge with good neurological status (CPC1-2) was found in 11.1% of the study population and in 27.6% when considering the Utstein comparator group of patients. A total of 216 (2.5%) patients arrived at the hospital with ongoing resuscitation, of whom only one survived with CPC1-2, and 165 (1.9%) patients were included in non-heart-beating donation programs.
CONCLUSIONS: In Spain with physician-led EMS, OHCA survival with CPC1-2 reached a reasonable percentage despite only a modest contribution of bystander BLS. Ongoing resuscitation strategy seems to be futile except when considering non-heart beating donation programs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Emergency medical services; Out-of-hospital cardiac arrest; Physician on board; Survival

Mesh:

Year:  2017        PMID: 28202420     DOI: 10.1016/j.resuscitation.2017.01.029

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  3 in total

1.  Impact of different waves of COVID-19 on emergency medical services and out-of-hospital cardiopulmonary arrest in Madrid, Spain.

Authors:  Jose-María Navalpotro-Pascual; Diana Monge Martín; Manuel-José González León; Fernando Neria Serrano; Carlos Alonso Blas; Belén Muñoz Isabel; Yago Muñecas Cuesta; Alfredo Carrillo Moya; Juan Les González; Alonso Mateos Rodríguez
Journal:  World J Emerg Med       Date:  2022

2.  Effects of a Clinical Simulation Course about Basic Life Support on Undergraduate Nursing Students' Learning.

Authors:  María Del Mar Requena-Mullor; Raquel Alarcón-Rodríguez; María Isabel Ventura-Miranda; Jessica García-González
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

3.  Physiological Response of Quality Cardiopulmonary Resuscitation, Crossover Trial on Mannequin in Extreme Temperature Conditions.

Authors:  José Luis Martin-Conty; Begoña Polonio-López; Clara Maestre-Miquel; Alicia Mohedano-Moriano; Carlos Durantez-Fernández; Laura Mordillo-Mateos; Jesús Jurado-Palomo; Antonio Viñuela; Juan José Bernal-Jiménez; Francisco Martin-Rodríguez
Journal:  Int J Environ Res Public Health       Date:  2020-08-12       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.